Finance

Beta
Lists
600479:SHA
ZhuZhou QianJin Pharmaceutical Co., Ltd
CN¥10.07
+0.70%
(+0.070) 1D
Jun 5, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600479...
Open
CN¥10.05
High
CN¥10.11
Low
CN¥10.04
Mkt. cap
4.96B
Avg. vol.
7.10M
Volume
2.85M
P/E ratio
14.68
52-wk high
CN¥11.53
52-wk low
CN¥9.86
EPS
CN¥0.69
Shares outstanding
418.51M
No. of employees
5K
Open
CN¥10.05
High
CN¥10.11
Low
CN¥10.04
Mkt. cap
4.96B
Avg. vol.
7.10M
Volume
2.85M
P/E ratio
14.68
52-wk high
CN¥11.53
52-wk low
CN¥9.86
EPS
CN¥0.69
Shares outstanding
418.51M
No. of employees
5K
News stories
From sources across the web
About ZhuZhou QianJin Pharmaceutical Co., Ltd
CEO-
Employees5.04K
Founded1966
Headquarters-
SectorPharmaceutical industry
Websitecnqjyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
812.98M
900.34M
910.51M
970.27M
Cost of goods sold
381.29M
450.97M
500.94M
495.55M
Cost of revenue
381.29M
450.97M
500.94M
495.55M
Research and development expenses
42.72M
40.72M
40.70M
38.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
286.77M
327.70M
246.01M
338.40M
Operating expense
329.12M
381.83M
284.40M
391.73M
Total operating expenses
710.41M
832.80M
785.33M
887.28M
Operating income
102.56M
67.54M
125.18M
82.99M
Other non operating income
-6.50M
2.30M
-49.38K
-1.87M
EBT including unusual items
114.90M
104.34M
136.39M
96.56M
EBT excluding unusual items
115.39M
103.38M
131.92M
92.29M
Income tax expense
13.18M
20.14M
18.95M
12.36M
Effective tax rate
11.47%
19.31%
13.89%
12.81%
Other operating expenses
6.50M
6.28M
8.06M
4.60M
Net income
74.57M
59.63M
98.94M
75.00M
Net profit margin
9.17%
6.62%
10.87%
7.73%
Earnings per share
-
-
-
-
Interest and investment income
19.34M
33.55M
6.79M
11.18M
Interest expense
-15.57K
-12.27K
-4.13K
-
Net interest expenses
19.33M
33.54M
6.79M
11.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
120.17M
86.59M
144.29M
102.10M
Gain or loss from assets sale
-8.83K
8.83K
-1.88M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more